Skip to main content
Premium Trial:

Request an Annual Quote

LAM IvyGene Test

Laboratory for Advanced Medicine has launched its non-invasive, epigenetics-based, laboratory-developed IvyGene test. IvyGene is designed to detect DNA methylation patterns consistent with the presence of cancer and provide quantitative data about the presence of cancer at the time of testing. It is intended to be used in conjunction with other diagnostic and confirmatory tests, including mammograms, PET scans and biopsies. To date, LAM said that the assay has been validated to detect four cancers: breast, colon, liver and lung, though the company has not yet published clinical validation results.